Cancer genomic medicine in Japan and the roles of pharmacists

被引：1
|
作者：
Aomori, Tohru [1 ,2 ]
Sakurai, Hiroomi [2 ]
Nishihara, Hiroshi [3 ]
机构：
[1] Keio Univ, Div Hosp Pharm Sci, Fac Pharm, Tokyo, Japan
[2] Keio Univ Hosp, Dept Pharm, Tokyo, Japan
[3] Keio Univ, Keio Canc Ctr, Genom Unit, Sch Med, Tokyo, Japan
来源：
PHARMACOGENETICS AND GENOMICS | 2022年 / 32卷 / 06期
关键词：
cancer genomic medicine; precision medicine;
D O I：
10.1097/FPC.0000000000000476
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Cancer genomic medicine (CGM) is a medical service that provides optimized treatment for each patient based on genes, biomarkers, environment, and lifestyle. In Japan, the approval of designed core hospitals for CGM started in 2017. In June 2019, two types of cancer gene panel tests became available in the national health insurance system, and CGM was socially implemented. While CGM is still in its infancy and there are some issues that need to be resolved, there are cases where the treatment has shown dramatic results. The present review highlights the CGM system in Japan, the issues it faces, and the role of pharmacists in this system.
引用
收藏
页码：242 / 245
页数：4
相关论文
共 50 条
  • [1] Roles of Pharmacists in Cancer Genomic Medicine
    Terada, Tomohiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2020, 140 (05): : 663 - 666
  • [2] Cancer genomic medicine in Japan
    Mano, Hiroyuki
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2020, 96 (07): : 316 - 321
  • [3] Development of Cancer Genomic Medicine Platform in Japan
    Mano, Hiroyuki
    Doki, Yuichiro
    Goto, Koichi
    CANCER SCIENCE, 2018, 109 : 611 - 611
  • [4] Establishment and implementation of Cancer Genomic Medicine in Japan
    Mukai, Yosuke
    Ueno, Hideki
    CANCER SCIENCE, 2021, 112 (03) : 970 - 977
  • [5] National Platform for Cancer Genomic Medicine in Japan
    Mano, Hiroyuki
    CANCER SCIENCE, 2023, 114 : 715 - 715
  • [6] Establishing and implementing cancer genomic medicine in Japan
    Ueno, Hideki
    Mukai, Yosuke
    Tanto, Shoji
    Sasaki, Masahiro
    CANCER SCIENCE, 2018, 109 : 613 - 613
  • [7] The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan
    Teruhiko Yoshida
    Yasushi Yatabe
    Ken Kato
    Genichiro Ishii
    Akinobu Hamada
    Hiroyuki Mano
    Kuniko Sunami
    Noboru Yamamoto
    Takashi Kohno
    Cancer Biology & Medicine, 2024, 21 (01) : 29 - 44
  • [8] The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan
    Yoshida, Teruhiko
    Yatabe, Yasushi
    Kato, Ken
    Ishii, Genichiro
    Hamada, Akinobu
    Mano, Hiroyuki
    Sunami, Kuniko
    Yamamoto, Noboru
    Kohno, Takashi
    CANCER BIOLOGY & MEDICINE, 2024, 21 (01) : 29 - 44
  • [9] Establishing a sustainable system for cancer genomic medicine in Japan
    Mukai, Yosuke
    Ueno, Hideki
    Tanto, Masaharu
    Sasaki, Masahiro
    CANCER SCIENCE, 2018, 109 : 786 - 786
  • [10] Pharmacists are key to clinical implementation of genomic medicine
    Weitzel, Kristin Wiisanen
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2018, 58 (06) : 593 - 595
12345